Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07672925 · ClinicalTrials.gov registry record · NA

FlowMD Feasibility Study

A NA study, sponsored by National University of Natural Medicine.

Recruiting
Registry status
NA
Development phase
40
Enrollment target

NCT07672925 is a NA study that is actively recruiting participants, run by National University of Natural Medicine. The registered enrollment target is 40 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07672925, a NA study, is actively recruiting participants, sponsored by National University of Natural Medicine.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

The goal of this clinical trial is to learn if the FlowMD mobile app is feasible to be used to manage mild anxiety in adults. It will also learn if the app is effective at managing anxiety in adults. Participants will: Use the FlowMD app daily to complete a 1-5 minute guided breathwork session over the course of 4 weeks. Complete surveys at the beginning, midpoint, and end of the study to measure anxiety levels and usability of the app.

Interventions

  • OTHER Intervention

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-10-15
Est. Completion 2026-12-31
Phase NA

What the Registry Record Tells You About NCT07672925

The ClinicalTrials.gov registry entry for NCT07672925 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National University of Natural Medicine, which has 30 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Intervention is the first listed.

NCT07672925 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07672925 about?

NCT07672925 is a clinical study titled "FlowMD Feasibility Study". The goal of this clinical trial is to learn if the FlowMD mobile app is feasible to be used to manage mild anxiety in adults. It will also learn if the app is effective at managing anxiety in adults. Participants will: Use the FlowMD app daily to complete a 1-5 minute guided breathwork session ove...

What is the current status of trial NCT07672925?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-10-15. Estimated completion is 2026-12-31.

What interventions are being tested in trial NCT07672925?

The interventions under investigation include: Intervention (OTHER).

Who is sponsoring clinical trial NCT07672925?

This trial is sponsored by National University of Natural Medicine, which has 30 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.